topiramate

Generic: topiramate

Labeler: remedyrepack inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name topiramate
Generic Name topiramate
Labeler remedyrepack inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

topiramate 25 mg/1

Manufacturer
REMEDYREPACK INC.

Identifiers & Regulatory

Product NDC 70518-2517
Product ID 70518-2517_4a64dcb0-35a6-7757-e063-6294a90a4a6c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA076343
Listing Expiration 2027-12-31
Marketing Start 2019-08-26

Pharmacologic Class

Mechanism of Action
cytochrome p450 3a4 inducers [moa] cytochrome p450 2c19 inhibitors [moa]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 705182517
Hyphenated Format 70518-2517

Supplemental Identifiers

RxCUI
199888
UNII
0H73WJJ391
NUI
N0000008486 N0000185506 N0000182140

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name topiramate (source: ndc)
Generic Name topiramate (source: ndc)
Application Number ANDA076343 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
source: ndc
Packaging
  • 100 POUCH in 1 BOX (70518-2517-1) / 1 TABLET in 1 POUCH (70518-2517-2)
source: ndc

Packages (1)

70518-2517-1 100 POUCH in 1 BOX (70518-2517-1) / 1 TABLET in 1 POUCH (70518-2517-2)

Ingredients (1)

topiramate (25 mg/1)

Linked Drug Pages (1)

Topiramate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4a64dcb0-35a6-7757-e063-6294a90a4a6c", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["199888"], "spl_set_id": ["c90d81a9-a87b-48b0-8cf1-172b82e30127"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "100 POUCH in 1 BOX (70518-2517-1)  / 1 TABLET in 1 POUCH (70518-2517-2)", "package_ndc": "70518-2517-1", "marketing_start_date": "20210805"}], "brand_name": "Topiramate", "product_id": "70518-2517_4a64dcb0-35a6-7757-e063-6294a90a4a6c", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "70518-2517", "generic_name": "Topiramate", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "25 mg/1"}], "application_number": "ANDA076343", "marketing_category": "ANDA", "marketing_start_date": "20190826", "listing_expiration_date": "20271231"}